291 related articles for article (PubMed ID: 33666830)
1. Limb-bud and Heart (LBH) mediates proliferation, fibroblast-to-myofibroblast transition and EMT-like processes in cardiac fibroblasts.
Wu A; Zhang L; Chen J; Li H; Yang P; Chen M; Liu Q
Mol Cell Biochem; 2021 Jul; 476(7):2685-2701. PubMed ID: 33666830
[TBL] [Abstract][Full Text] [Related]
2. Limb-Bud and Heart (LBH) Upregulation in Cardiomyocytes under Hypoxia Promotes the Activation of Cardiac Fibroblasts via Exosome Secretion.
Xu Y; Wu A; Chen J; Song X; Chen M; Liu Q
Mediators Inflamm; 2022; 2022():8939449. PubMed ID: 36110098
[TBL] [Abstract][Full Text] [Related]
3. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
4. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
5. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
[TBL] [Abstract][Full Text] [Related]
6. C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation.
Lei H; Wu D; Wang JY; Li L; Zhang CL; Feng H; Fu FY; Wu LL
Basic Res Cardiol; 2015; 110(4):35. PubMed ID: 25962701
[TBL] [Abstract][Full Text] [Related]
7. The Ski-Zeb2-Meox2 pathway provides a novel mechanism for regulation of the cardiac myofibroblast phenotype.
Cunnington RH; Northcott JM; Ghavami S; Filomeno KL; Jahan F; Kavosh MS; Davies JJ; Wigle JT; Dixon IM
J Cell Sci; 2014 Jan; 127(Pt 1):40-9. PubMed ID: 24155330
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
9. Limb-bud and heart (LBH) inhibits cellular migration, invasion and epithelial-mesenchymal transition in nasopharyngeal carcinoma via downregulating αB-crystallin expression.
Wu A; Zhang L; Luo N; Zhang L; Li L; Liu Q
Cell Signal; 2021 Sep; 85():110045. PubMed ID: 34000384
[TBL] [Abstract][Full Text] [Related]
10. Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7.
Yuan J; Chen H; Ge D; Xu Y; Xu H; Yang Y; Gu M; Zhou Y; Zhu J; Ge T; Chen Q; Gao Y; Wang Y; Li X; Zhao Y
Cell Physiol Biochem; 2017; 42(6):2207-2219. PubMed ID: 28817807
[TBL] [Abstract][Full Text] [Related]
11. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-β1/Smad3 signaling.
Zhou XL; Fang YH; Wan L; Xu QR; Huang H; Zhu RR; Wu QC; Liu JC
J Cell Physiol; 2019 Jun; 234(6):8834-8845. PubMed ID: 30317638
[TBL] [Abstract][Full Text] [Related]
13. Gut microbe-derived metabolite trimethylamine N-oxide accelerates fibroblast-myofibroblast differentiation and induces cardiac fibrosis.
Yang W; Zhang S; Zhu J; Jiang H; Jia D; Ou T; Qi Z; Zou Y; Qian J; Sun A; Ge J
J Mol Cell Cardiol; 2019 Sep; 134():119-130. PubMed ID: 31299216
[TBL] [Abstract][Full Text] [Related]
14. Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.
Li T; Zhuang Y; Yang W; Xie Y; Shang W; Su S; Dong X; Wu J; Jiang W; Zhou Y; Li Y; Zhou X; Zhang M; Lu Y; Pan Z
FASEB J; 2021 Feb; 35(2):e21162. PubMed ID: 33150686
[TBL] [Abstract][Full Text] [Related]
15. Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling.
Wu A; Luo N; Xu Y; Du N; Li L; Liu Q
Int J Biol Sci; 2022; 18(1):242-260. PubMed ID: 34975330
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of eIF3a ameliorates cardiac fibrosis by inhibiting the TGF-β1/Smad3 signaling pathway.
Li B; Chen H; Yang X; Wang Y; Qin L; Chu Y
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):97-101. PubMed ID: 27453280
[TBL] [Abstract][Full Text] [Related]
17. Retinoid X receptor agonists alleviate fibroblast activation and post-infarction cardiac remodeling via inhibition of TGF-β1/Smad pathway.
Lin XY; Chu Y; Zhang GS; Zhang HL; Kang K; Wu MX; Zhu J; Xu CS; Lin JX; Huang CK; Chai DJ
Life Sci; 2023 Sep; 329():121936. PubMed ID: 37453576
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
Liu X; Xu Y; Deng Y; Li H
Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
[TBL] [Abstract][Full Text] [Related]
19. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II upregulates fibroblast-myofibroblast transition through Cx43-dependent CaMKII and TGF-β1 signaling in neonatal rat cardiac fibroblasts.
Cao L; Chen Y; Lu L; Liu Y; Wang Y; Fan J; Yin Y
Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):843-852. PubMed ID: 30060053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]